Autoimmune Neurologist, Professor of Neurology, and Laboratory Medicine & Pathology, Mayo Clinic, Rochester
Joined August 2020
- Tweets130
- Following112
- Followers991
- Likes254
Divyanshu Dubey retweeted
📢 Applications open for the 2027 Muscle Disorders Fellowship at @MayoClinic!
Advanced training in muscle diseases for neurology residents, #neuromuscular fellows & eligible IMGs (USMLE + ECFMG).
Learn more: college.mayo.edu/academics/r…
Our latest work in Annals of Neurology: LGI1-AE shows disease specific limbic + striatal atrophy linked to regional LGI1 expression. Greater cognitive impairment predict hippocampal atrophy—highlighting the importance of early diagnosis & treatment.
onlinelibrary.wiley.com/doi/…
Truly a team effort with
@burcuzeydanmd @albertaboseif @ANASTASIA_ZEK @EoinFlanagan14 @Mayo_AING and colleagues! 🧠👏
We originally developed the APE2 score to help identify patients with a higher likelihood of antibody-associated autoimmune seizures/encephalitis and guide antibody testing. Nice to see continued evaluation of its diagnostic utility.
The APE2 score may be more sensitive and inclusive for diagnosing AE than the traditional criteria: Utility of the APE2 Score as a Diagnostic Tool for Autoimmune Encephalitis - Basu - Annals of Clinical and Translational Neurology - Wiley Online Library onlinelibrary.wiley.com/doi/…
Proud to be part of a team committed to advancing biomarker discovery and improving diagnostic care for patients with rare autoimmune neurological diseases.
For patients living with rare autoimmune neurological conditions, answers can be difficult to find. Mayo Clinic Laboratories is committed to advancing research that improves diagnostic accuracy.
Learn more in this "Eye on Innovation."
bit.ly/4dYdV68
Thank you for the invitation and the warm welcome. Thoroughly enjoyed the insightful discussions with everyone at @NIMHANS_BLR.
Always an honour and pleasure to hear Dr. Divyanshu Dubey sir speak — incredible update on autoantibody-mediated neurological disease. Grateful for the learning! 🧠@Div_Dubey @NIMHANS_BLR
In this @JAMANeuro Viewpoint, we discuss why continued autoantibody discovery matters. Today's seronegative patient may become tomorrow's newly recognized disease. Discovery advances diagnosis, reveals disease mechanisms & guides targeted therapies.
jamanetwork.com/journals/jam…
As antibody discovery continues to reshape #Neuroimmunology, phenotype-specific testing is becoming essential for autoimmune neurologic disorders. Glad to share insights with @mayocliniclabs & highlight our labs collaborative, innovative approach to advancing the field.
Autoimmune neurology testing has evolved beyond limited paraneoplastic evaluations to phenotype-specific panels that identify clinically relevant antibodies. This approach significantly improves diagnostic accuracy for complex neurological diseases. bit.ly/4dYdV68
Divyanshu Dubey retweeted
Congratulations to the incredible Class of 2026 Neurology Fellows on graduation! 🎓
“The glory of medicine is that it is constantly moving forward, that there is always more to learn.” - Dr. William J Mayo
Wishing you success as you carry medicine forward ! #mayoneurofellows
Decades of rippling & mounding. Cavin-4 autoantibody, identified at Mayo Clinic, guided rituximab therapy, with sustained clinical remission and cavin-4 IgG seronegativity, highlighting role of biomarker discovery in rare autoimmune neuromuscular disease.
jamanetwork.com/journals/jam…
A very interesting program for clinicians, researchers, and trainees interested in #Neuroimmunology.
Registration is now OPEN for Autoantibody Summit 2026 on Sept 17–18 in London, ON! Focus is #Neuroimmunology with talks on #AE, #NMOSD, #MOGAD, #CIDP, #MG and other autoimmune dx. Early registration is only $200 and space is limited. Register here today:
autoantibodynetwork.com/Cont…
New Cell Reports Medicine study extends synaptophysin autoimmunity to cerebellar ataxia and provides mechanistic evidence of pathogenicity. Builds on our prior identification of synaptophysin in neurological autoimmunity and expands the clinical phenotype cell.com/cell-reports-medici…
Divyanshu Dubey retweeted
📣We have an opening for the 1 yr Muscle fellowship at Mayo clinic to start this summer. You have to be ACMG certified and have completed Neuro or peds Neuro residency in the US or abroad.
Send me a message if interested and I’ll forward the request to prog. director!
Divyanshu Dubey retweeted
Register for our webinar on May 19 to learn how phenotype-driven autoimmune neurology testing supports more accurate diagnosis, more meaningful interpretation of antibody results, and improved clinical decision-making in autoimmune neurological disease. bit.ly/3O8xmPv
Divyanshu Dubey retweeted
SAVE THE DATE: The 18th Autoantibody Summit is in London, ON Sept 17-18 2026 and focuses on #Neuroimmunology! Will cover #AE, #NMOSD, #MOGAD, #MG, and other autoimmune dx. Link to program below. Registration opens later this month; hope to see you there!
autoantibodynetwork.com/Cont…
Would be great to see strong representation from the autoimmune neurology community—always a fantastic meeting for sharing work and connecting.
Grateful for our team effort featured by Mayo Clinic News Network—developing a blood test to detect germ cell tumors missed by standard markers.
newsnetwork.mayoclinic.org/d…
Looking forward to #AANAM in Chicago—representatives from our Mayo Neuroimmunology Lab team will be at booth #5018 over the lunch hour. Stop by, connect, and explore what’s ahead in neurodiagnostics.
Save the date! The American Academy of Neurology Annual Meeting is coming to Chicago, April 19–22, and our neurology experts will be there.
Connect with us at booth #5018 to explore what’s next in diagnostic innovation. #AANAM bit.ly/41fXSJJ
Excited to share our study in @NatureComms. Immunosignatures decode tumor–immune interactions in testicular cancer, extrapolating beyond paraneoplastic autoimmunity. 93% sensitivity, 99% specificity, including biomarker-negative cases. #CancerImmunology nature.com/articles/s41467-0…
